2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab Vedotin in Patients With Locally Advanced or Metastatic Urothelial Cancer"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Daniel Petrylak
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Daniel Petrylak
169 views
June 6, 2024
Chapters
Introduction & Enfortumab Vedotin Overview
00:00
Study Schema & Dose Modifications
01:26
Efficacy Across Different Doses & Trials
04:14
Dose Reduction Impact on Treatment Outcomes
07:30
Safety, Efficacy & Conclusion
09:45
Comments 0
Login to view comments.
Click here to Login
GU